N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia.
about
Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as TherapyEmotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsAltered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration.Cognitive Effort and Schizophrenia Modulate Large-Scale Functional Brain ConnectivityKetamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex.A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic PathwayEarly-course unmedicated schizophrenia patients exhibit elevated prefrontal connectivity associated with longitudinal change.Brain in flames - animal models of psychosis: utility and limitationsKetamine Dysregulates the Amplitude and Connectivity of High-Frequency Oscillations in Cortical-Subcortical Networks in Humans: Evidence From Resting-State Magnetoencephalography-RecordingsRole of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia.DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain.Disrupted sensorimotor and social-cognitive networks underlie symptoms in childhood-onset schizophrenia.Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockadeState-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effectsSpecies-conserved reconfigurations of brain network topology induced by ketamineTherapeutic Modulation of Glutamate Receptors in Major Depressive DisorderFunctional brain connectivity phenotypes for schizophrenia drug discovery.Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research.Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.Searching for Cross-Diagnostic Convergence: Neural Mechanisms Governing Excitation and Inhibition Balance in Schizophrenia and Autism Spectrum Disorders.Social Preference and Glutamatergic Dysfunction: Underappreciated Prerequisites for Social Dysfunction in Schizophrenia.Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective.Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.Ketamine Treatment and Global Brain Connectivity in Major Depression.Ketamine-dependent neuronal activation in healthy volunteers.Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteersFragile temporal prediction in patients with schizophrenia is related to minimal self disorders.Resting-State Functional Connectivity-Based Biomarkers and Functional MRI-Based Neurofeedback for Psychiatric Disorders: A Challenge for Developing Theranostic Biomarkers.Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus.MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice.Attenuated resting-state functional connectivity in patients with childhood- and adult-onset schizophrenia.From Maps to Multi-dimensional Network Mechanisms of Mental Disorders.The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders.Ketamine-induced changes in connectivity of functional brain networks in awake female nonhuman primates: a translational functional imaging model.Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action.Hippocampal Neural Disinhibition Causes Attentional and Memory Deficits.The predictive coding account of psychosisComputational Modeling of Contrast Sensitivity and Orientation Tuning in First-Episode and Chronic Schizophrenia
P2860
Q26773084-F6D426B0-DEA9-4E0C-BDD7-085FA0DF0820Q28073684-6538A511-A451-4F28-A85D-375C85CCCD72Q30647676-4D22ED1B-F4D7-42DB-A158-32194DFE7875Q30667666-D64376C4-C3E6-49FE-BFFC-72E4EDDF364FQ30758231-49F43AE0-2880-4A71-AFCB-E50340D7051EQ33607904-79531566-353A-4C6A-8CC5-137739AF5E15Q34869701-4C2EDF18-5C6C-4DEA-B9FA-CAB55206E4DFQ35683865-6E75EAFE-AE83-45AF-8950-690805314CCCQ35950825-CD395AAC-0AB6-4F0B-8A1D-7335E7E32366Q36137795-5BC38179-EE9C-456A-8D45-ACE4C4A9502AQ36310447-B9A0C12A-AE5E-488E-8E8E-8D64ECBAF71EQ36481738-72B7E224-D96A-4B7A-8674-A63911154F94Q36609798-BC01620D-F393-41EA-A247-6C2A7F8A4CBAQ36732752-F7159DB5-BFCF-409F-B6B6-71D79446E4EFQ36915397-661C7EEC-D5B4-46AB-9CFE-9853E5868A02Q37668014-3607C654-F1E4-4038-9A33-E16B455F5B2EQ38310759-D751C8F0-7B85-4433-946A-E009F19BD06FQ38669576-ACEB760C-0C34-4F97-A9AD-1FA87A20D12EQ38677502-8E0E7673-946A-41C3-940B-27F015683CE0Q38691885-A480997A-FD30-4323-ABC6-43806A183D9EQ38914274-3A79E69D-6B18-49F4-87DE-E12FD158314CQ38937415-9589AEC3-7F0B-4C57-A523-CD71CC43DB7FQ39180685-563A9A0C-C085-40D8-B245-F4E0A16263A5Q39257224-2D5EAFF8-D9FB-4461-97B6-6BBF0C780334Q39287296-A1A4CF22-C39F-426F-875E-11D77D9558C0Q39413238-9522E90A-BB05-48E2-81CA-57607BF55453Q39437669-D6D8E128-B798-4368-B688-49E47EB4AB71Q39536837-039A9BF5-2C61-47AE-8370-3A7DD7A7EC76Q41418621-C7EE9BCF-39FE-4FE5-995B-82398491D620Q42271275-7AC717E4-951D-408B-ACE2-98CB89AC0A5BQ44179800-5AF1D4B6-705C-47A9-8956-3F67D533A4A2Q45051337-B8F1E0A2-F800-4C3D-9793-8E5FBBF412D4Q47195853-8922FE44-23AD-40EE-87B7-DF31B0A4BECBQ47200572-0AF436B3-7090-4B54-8383-9874DEDD1286Q47382890-FC1E55E3-7B86-4651-BF6D-AA062ABCB1D9Q47398245-DBB4553E-0ADD-4834-9959-24B1F36CA00BQ47734586-820E6B5B-6A62-4625-916D-156D5C674813Q50491498-4C1EC62C-DA1A-42D0-9ADA-8BDD33099F45Q54402848-18B0C3A4-A73F-4CCC-B011-C7E656783AA8Q58163973-91815C39-BB48-4A59-9C5C-6B49237DB0F1
P2860
N-methyl-D-aspartate receptor antagonist effects on prefrontal cortical connectivity better model early than chronic schizophrenia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@en
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@nl
type
label
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@en
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@nl
prefLabel
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@en
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@nl
P2093
P50
P1476
N-methyl-D-aspartate receptor ...... ly than chronic schizophrenia.
@en
P2093
Alan Anticevic
Aleksandar Savic
Grega Repovs
John H Krystal
Mark Gancsos
Naomi R Driesen
Peter T Morgan
Yanqing Tang
P304
P356
10.1016/J.BIOPSYCH.2014.07.022
P407
P577
2014-07-31T00:00:00Z